Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer
NCT ID: NCT02289053
Last Updated: 2017-05-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1623 participants
OBSERVATIONAL
2006-04-01
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Diverticular Disease on the Detection of Colon Adenomas
NCT02057562
Computer Assisted Measurement of Colorectal Polyps
NCT02970760
The Study of Adenoma Characteristics of the COX-2 and DNMT Expressions in the Index Colonoscopy to Predict the Polyp Recurrence During Surveillance
NCT05568810
Detection and Classification of Colon Polyps
NCT00825292
Safety and Efficacy of Endocuff-assisted Colonoscopy for Adenoma Detection.
NCT02374515
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Positive Family History
Eligible participants with a family history of colorectal cancer or polyps will be grouped into the "subjects" group.
No interventions assigned to this group
Average Risk Patients
Eligible participants without a family history of colorectal cancer or polyps will be grouped into the "control" group.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 40-49 year old asymptomatic men and women referred for colorectal cancer screening with a family history of polyps in a first degree relative;
* 40-49 year old men and women without a family history of CRC or polyps in a first degree relative who are referred for colonoscopy to evaluate scant hematochezia characterized as red blood on toilet tissue after wiping or small droplets of blood on stool or in toilet water after evacuating stool, abdominal discomfort or altered bowel habits characterized as constipation or diarrhea.
Exclusion Criteria
* Personal history of iron deficiency without anemia within six months of referral;
* Personal history of (+) FOBT within one year of referral;
* Personal history of previous colonoscopy or barium enema within the past 10 years;
* Personal history of previous flexible sigmoidoscopy in the past 5 years;
* Personal history of adenoma, colorectal cancer, inflammatory bowel disease, HNPCC, or familial adenomatous polyposis (FAP);
* Unintentional weight loss \> 10 lbs within the previous six months;
* Individuals with family history of CRC AND scant hematochezia;
* Inability to speak and read English.
40 Years
49 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Philip Schoenfeld
Professor of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philip Schoenfeld, MD
Role: PRINCIPAL_INVESTIGATOR
University of Michigan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Walter Reed National Military Medical Center
Bethesda, Maryland, United States
Ann Arbor VA Healthcare System
Ann Arbor, Michigan, United States
University of Michigan
Ann Arbor, Michigan, United States
John D. Dingell VA Medical Center
Detroit, Michigan, United States
Huron Gastro
Ypsilanti, Michigan, United States
Durham VA Medical Center
Durham, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
K24-DK
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.